{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:26:33Z","timestamp":1773264393707,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ijantimicag.2006.08.042","type":"journal-article","created":{"date-parts":[[2006,12,23]],"date-time":"2006-12-23T12:14:17Z","timestamp":1166876057000},"page":"34-38","source":"Crossref","is-referenced-by-count":25,"title":["Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin\/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital"],"prefix":"10.1016","volume":"29","author":[{"given":"George","family":"Petrikkos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Markogiannakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Papapareskevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Daikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Stefanakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas P","family":"Zissis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Avlamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.08.042_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1086\/647837","article-title":"Antimicrobial resistance and resistance in eight US hospitals: complexities of analysis and modelling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals","volume":"19","author":"Monnet","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1073\/pnas.97.4.1938","article-title":"The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions","volume":"97","author":"Lipsitch","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1012742314070","article-title":"Antimicrobial utilization and antimicrobial resistance at three different hospitals","volume":"17","author":"Vlahovi\u0107-Pal\u010devski","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijantimicag.2005.08.016","article-title":"Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991\u20132003 from a university hospital in Taiwan","volume":"26","author":"Hsueh","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/clinids\/23.1.118","article-title":"Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center","volume":"23","author":"Rice","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3949\/ccjm.70.9.793","article-title":"Controlling antibiotic resistance in the ICU: different bacteria, different strategies","volume":"70","author":"Rice","year":"2003","journal-title":"Cleve Clin J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2006.08.042_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1469-0691.2000.00002.x","article-title":"Extended spectrum \u03b2-lactamases: how big is the problem?","volume":"6","author":"Rahal","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jinf.2005.01.005","article-title":"Clinical implications of extended spectrum \u03b2-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness","volume":"51","author":"Kotapati","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/AAC.42.1.53","article-title":"Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended spectrum \u03b2-Iactamases","volume":"42","author":"Pena","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijantimicag.2004.01.010","article-title":"Determining incidence of extended spectrum (-Iactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centers from 17 countries: the PEARLS study 2001\u20132002","volume":"24","author":"Bouchillon","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum \u03b2-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Petersen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/jac\/dkl097","article-title":"Impact of diversity of antibiotic use on the development of antimicrobial resistance","volume":"57","author":"Sandiumenge","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-119-5-199309010-00001","article-title":"Nosocomial outbreak of Klebsiella pneumoniae resistant to late-generation cephalosporins","volume":"119","author":"Meyer","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/AAC.48.2.392-395.2004","article-title":"Replacement of broad-spectrum cephalosporins by piperacillin\u2013tazobactam: impact on sustained high rates of bacterial resistance","volume":"48","author":"Bantar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib15","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth Informational Supplement. M100-S15. Wayne, PA: CLSI; 2005."},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2006.08.042_bib16","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1093\/clinids\/24.Supplement_1.S157","article-title":"Surveillance of antimicrobial resistance: the WHONET program","volume":"24","author":"Stelling","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0732-8893(95)00076-M","article-title":"A team approach to hospital formulary replacement","volume":"22","author":"Lee","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/BF01700557","article-title":"Implementation of an educational program and of an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine","volume":"16","author":"Gyssens","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.5694\/j.1326-5377.1994.tb138316.x","article-title":"Improving the quality of antibiotic prescription patterns in general practice: the role of educational intervention","volume":"160","author":"De Santis","year":"1994","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/514743","article-title":"Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary","volume":"28","author":"Landman","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/375818","article-title":"A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings and bacterial resistance","volume":"37","author":"Bantar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0924-8579(02)00392-8","article-title":"Evaluation of antibiotic use in a hospital with an antibiotic restriction policy","volume":"21","author":"Erbay","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib23","first-page":"182","article-title":"Association of antibiotic utilization measures and reduced incidence of infections with extend-spectrum \u03b2-lactamase-producing organisms","volume":"36","author":"Lan","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2006.08.042_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0924-8579(02)00361-8","article-title":"Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals","volume":"21","author":"Tzelepi","year":"2003","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790600389X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790600389X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T10:17:15Z","timestamp":1556014635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485790600389X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S092485790600389X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.08.042","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}